Bal Pharma Board Meeting on Aug 12 to Approve Q1 FY27 Results

Bal Pharma Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the first quarter of the fiscal year 2026-27, ending June 30, 2026. The meeting will also address any other matters deemed necessary by the Chair, in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.